Wounds have been a constant fact of Aaron Owens’ life. His skin is so fragile that friction that would be trivial to others — rolling over in bed, weight shifting against the seat as the car turns — could scrape off his tissue. He didn’t like being in public sometimes because people would stare at the boy covered in bandages.
When he enrolled in a clinical trial a few years ago, the teenager didn’t know which wound on his body was treated with the experimental medication, and which was dosed with a placebo. This trial wasn’t like so many others where some enrollees get the drug in question and others get a sham dose. Rather, Owens received both, but on different wounds.
Soon, though, Owens noticed that portions of skin in some areas started to heal, and heal faster and stronger than he had experienced in his lifetime contending with these wounds. It was a clue that, maybe, the medication was working.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect